ARDT Stock Analysis: Buy, Sell, or Hold?
ARDT - Ardent Health, Inc.
$10.82
0.00 (0.00%)
▲
5d:
+8.96%
30d:
+25.81%
90d:
+20.89%
HOLD
MODERATE Confidence
Analysis Updated: Jul 7, 2026 12:00 AM ET
Earnings: Aug 04, 2026
26d
Get Alerted When ARDT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ARDT trades at premium valuation expecting 5.3% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: ARDT trades at premium valuation expecting 5.3% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$11.53
Based on 4.4% avg growth
INTRINSIC VALUE TODAY
$7.16
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ARDT is currently trading at $10.82, which is considered extended relative to its 30-day fair value range of $8.76 to $10.12. From a valuation perspective, the stock is trading at a premium (Forward PE: 8.2) compared to its historical average (7.1). At these levels, the market is pricing in 5.3% annual earnings growth.
Technical Outlook: Technically, ARDT is showing sideways momentum. The price is approaching resistance at $11.03. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ARDT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.32 (+13.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ARDT is showing sideways momentum. The price is approaching resistance at $11.03. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ARDT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.32 (+13.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$8.76 -
$10.12
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
58.1%
All Signals
- BEARISH: Price extended above range (+6.9% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($12.32)
- BULLISH: Expecting earnings turnaround to 5.3% growth with 7.0% revenue growth
Trading Range Analysis
30-Day Trading Range
$8.76 -
$10.12
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$8.98
Resistance Level
$11.03
Current Trend
Sideways
Technical data as of
Jul 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.24
Wall Street Target
$12.32
(+13.8%)
Revenue Growth (YoY)
7.0%
Earnings Growth (YoY)
-3.4%
Profit Margin
2.1%
Valuation Premium vs History
+5.3% premium
PE vs Historical
8.2 vs 7.1
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.3%
(market-implied from PE analysis)
1-Year Target
$11.39
(+5%)
2-Year Target
$12.00
(+11%)
3-Year Target
$12.63
(+17%)
3-Yr Target (if PE normalizes)
(PE: 8→7)
PE COMPRESSION
$10.88
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 4.7%)
$32.83
(+203%)
Base:
(SPY PE: 8.2, Growth: 4.7%)
$12.43
(+15%)
Bear:
(PE: 7.0, Growth: 4.7%)
$10.56
(-2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (12x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 11.51 | Current EPS (TTM): $0.94
Bull Case
$16.62
(+54%)
Analyst growth 39.6%, PE expands to 12.7
Base Case
$15.11
(+40%)
Market implied 39.6%, PE stable at 11.5
Bear Case
$7.36
(-32%)
Severe decline -20.0%, PE contracts to 9.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 08, 2026 4:40 AM ET
Data refreshes hourly during market hours. Next update: 5:40 AM
Data refreshes hourly during market hours. Next update: 5:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARDT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$243 | 58 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$500 | 67 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 58 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 52 HOLD |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 62 BUY |
